SEPRAFILM
Seprafilm is a mechanical bioresorbable adhesion barrier that is applied to adhesiogenic tissues before surgical closure. It is indicated for the reduction in the incidence, extent, and severity of postoperative adhesions in patients undergoing abdominal or pelvic laparotomy.
SEPRAFILM
Industry:
Health Care
Founded:
1996-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.seprafilm.us
Status:
Closed
Technology used in webpage:
DigiCert SSL
Similar Organizations
Mineral Air
Mineral Air offers a range of cosmetics and skin care products.
More informations about "Seprafilm"
What is Seprafilm Adhesion Barrier?
Seprafilm Adhesion Barrier can be cut and tailored to fit the size and shape of the surgical area. 1 Once in place, it adheres to the tissue and forms a barrier. 1 The application process is …See details»
Seprafilm - Crunchbase Company Profile & Funding
9,833 Number of Organizations • $65.7B Total Funding Amount • 7,478 Number of Investors. Track . ... Seprafilm is located in Bridgewater, New Jersey, United States. Who are Seprafilm …See details»
Baxter Completes Acquisition of Seprafilm Adhesion Barrier
Feb 18, 2020 PDF . DEERFIELD, Ill. - 2020-02-18 Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition …See details»
Seprafilm - Baxter
Seprafilm® Adhesion Barrier DESCRIPTION Seprafilm® Adhesion Barrier (Seprafilm) is a sterile, bioresorb-able, translucent membrane composed of two chemically modified anionic …See details»
SEPRAFILM - Baxter specialty Site
SEPRAFILM Adhesion Barrier is an adhesion barrier that reduces the incidence, extent and severity of adhesions following abdominopelvic surgery 1,2. ... About Us Every day, millions of …See details»
Seprafilm Adhesion Barrier - Baxter
SEPRAFILM Adhesion Barrier efficacy in abdominal surgery In a randomized, prospective, double-blinded, multicenter clinical study involving 183 patients [175 evaluable] with ulcerative …See details»
EIFU_0719002044 Seprafilm-PackageInsert_US_v3 13JUL2020
Baseline characteristics from the United States, Canada, and Europe who underwent intestinal resections or adhesiolysis for treatment of bowel obstruction. Although there was no difference …See details»
Sanofi trades Seprafilm unit to Baxter for $350M in cash ahead of ...
Dec 2, 2019 Sanofi has moved to offload its Seprafilm surgical barrier business, setting up a large infusion of cash for early next year as its new CEO prepares to unveil his new strategic …See details»
Seprafilm ® and adhesive small bowel obstruction in colorectal ...
Oct 5, 2024 Background The efficacy of Seprafilm® in preventing clinically significant adhesive small bowel obstruction (ASBO) is controversial and deserves further review. The aim of this …See details»
Seprafilm® adhesion barrier: (1) a review of preclinical, animal, …
Preclinical evaluation of the efficacy of Seprafilm in a rat cecal abrasion or side wall injury model demonstrated that Seprafilm significantly reduced the incidence of cecal adhesions (P < …See details»
Baxter Completes Acquisition of Seprafilm Adhesion Barrier
Feb 18, 2020 Acquired product line is strong complement to the company’s leading Advanced Surgery portfolio Global integration process begins immediately to manage successful …See details»
SEPRAFILM - Baxter Advanced Surgery
SEPRAFILM Adhesion Barrier is an adhesion barrier that reduces the incidence, extent and severity of adhesions following abdominopelvic surgery 1,2. ... About Us Every day, millions of …See details»
SEPRAFILM ADHESION BARRIER 510(k) FDA Approval
Approval for revised labeling for seprafilm adhesion barrier to reflect the interim findings of the study approved under g980066, "a prospective, randomized, multicenter, controlled evaluation …See details»
Long-Term Efficacy and Safety of Adhesion Prevention Agents in
Oct 11, 2024 Our review highlights that agents like bioresorbable membranes (Seprafilm) and icodextrin significantly reduce the incidence and severity of adhesions, particularly in high-risk …See details»
Sepraspray, a new option for reduction of postoperative adhesions
OBJECTIVE: Seprafilm™ is highly efficacious in reducing postoperative adhesions after open surgical procedures, but laparoscopic delivery is difficult. This study assesses safety and …See details»
BAXTER COMPLETES ACQUISITION OF SEPRAFILM ADHESION …
Anastomotic leak and related events (fistula, abscess, leak, sepsis, peritonitis). Seprafilm Adhesion Barrier must be used according to the instructions for use. Seprafilm Adhesion …See details»
Seprafilm Adhesion Barrier Application In Hepatectomy - YouTube
Feb 1, 2023 Seprafilm Adhesion Barrier Application In HepatectomyThis YouTube channel is intended for Healthcare Professionals outside of the US and the UK only. This is...See details»
Seprafilm ® and adhesive small bowel obstruction in colorectal ...
Oct 5, 2024 Background: The efficacy of Seprafilm ® in preventing clinically significant adhesive small bowel obstruction (ASBO) is controversial and deserves further review. The aim of this …See details»
Efficacy and safety of Seprafilm for preventing intestinal …
Jan 21, 2021 The Seprafilm group had lower incidence of intestinal obstruction (RR, 0.52; 95% CI, 0.38–0.70; p < .0001), reoperation rates due to intestinal obstruction (RR, 0.48; 95% CI, …See details»